Sergey Vasnetsov - 30 Dec 2022 Form 4 Insider Report for ASP Isotopes Inc. (ASPI)

Reporting relationship: Director
Issuer ticker: ASPI
Reported as of: 30 Dec 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Feb 2023, 08:58:45 UTC
Prior SEC filing: 16 Nov 2022
Next SEC filing: 08 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Sergey Vasnetsov

Key filing fact

Sergey Vasnetsov filed Form 4 for ASP Isotopes Inc. (ASPI) on 22 Feb 2023.

Key facts

This page summarizes Sergey Vasnetsov's Form 4 filing for ASP Isotopes Inc. (ASPI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Feb 2023, 08:58.

Change

Previous filing in this sequence was filed on 16 Nov 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASPI transaction

Common Stock

Award

Transaction value: $0
Shares: +500,000
Change %: +18%
Price: $0.000000
Shares after: 3,300,000
Date: 30 Dec 2022
Ownership: See Footnote
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On December 30, 2022, the Company issued a bonus of 500,000 shares of the Company's restricted common stock to Sergey Vasnetsov, our director, for services provided during the fiscal year ended December 31, 2022 by ChemBridges LLC ("ChemBridge") a Puerto Rico limited liability company controlled by Sergey Vasnetsov as its manager. 125,000 shares of the common stock vest on each March 30, 2023, June 30, 2023, September 30, 2023 and December 30, 2023.

Footnote F2

Mr. Vasnetsov beneficially owns 1,000,000 common shares indirectly through Elista LLC and beneficially owns 2,300,000 common shares indirectly through ChemBridges LLC.